Exhibit 99.2
AUTOLUS LIMITED
(PREDECESSOR to AUTOLUS THERAPEUTICS PLC)
CONDENSED BALANCE SHEETS
(UNAUDITED)
(In thousands, except share and per share amounts)
| March 31, 2018 | September 30, 2017 | |||||||
Assets | ||||||||
Current assets: | ||||||||
Cash | $ | 120,674 | $ | 137,070 | ||||
Prepaid expenses and other current assets | 11,198 | 5,412 | ||||||
|
|
|
| |||||
Total current assets | 131,872 | 142,482 | ||||||
Non-current assets: | ||||||||
Property and equipment, net | 11,590 | 6,180 | ||||||
|
|
|
| |||||
Total assets | $ | 143,462 | $ | 148,662 | ||||
|
|
|
| |||||
Liabilities and shareholders’ equity | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ | 3,613 | $ | 1,946 | ||||
Accrued expenses and other liabilities | 11,888 | 3,087 | ||||||
|
|
|
| |||||
Total current liabilities | 15,501 | 5,033 | ||||||
Non-current liabilities: | ||||||||
Long-term lease incentive obligation | 258 | 265 | ||||||
Other long-term payables | 604 | 763 | ||||||
|
|
|
| |||||
Total liabilities | 16,363 | 6,061 | ||||||
Shareholders’ equity: | ||||||||
Preferred shares, £0.00001 par value; 78,143,548 shares authorized, 78,002,897 and 78,143,548 shares issued and outstanding as of September 30, 2017 and March 31, 2018, respectively | 1 | 1 | ||||||
Ordinary shares, £0.00001 par value; 119,203,434 shares authorized, 17,428,434 and 17,414,585 shares issued and outstanding at September 30, 2017 and March 31, 2018, respectively | — | |||||||
Additionalpaid-in capital | 196,981 | 194,351 | ||||||
Accumulated other comprehensive loss | 2,258 | (3,849 | ) | |||||
Accumulated deficit | (72,141 | ) | (47,902 | ) | ||||
|
|
|
| |||||
Total shareholders’ equity | 127,099 | 142,601 | ||||||
|
|
|
| |||||
Total liabilities and shareholders’ equity | $ | 143,462 | $ | 148,662 | ||||
|
|
|
| |||||
